“…Figure 1 presents the process by which we identified 302 relevant studies in the four databases. After removing the duplicates, we screened 223 studies based on the titles and contents of the abstracts and excluded 214 that did not meet our inclusion criteria, leaving nine for further evaluation [ 43 , 52 , 53 , 67 , 75 , 76 , 77 , 78 , 79 ]. After examining the full texts of these articles, we excluded four clinical trials [ 50 , 76 , 77 , 80 ] because of a lack of a comparison group or of clarity regarding the number of PHN patients who received acyclovir.…”